These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21843378)

  • 1. Dopaminergic imaging: clinical utility now and in the future.
    Walker Z; Rodda J
    Int Psychogeriatr; 2011 Sep; 23 Suppl 2():S32-40. PubMed ID: 21843378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dementia with Lewy bodies versus Alzheimer's disease: role of dopamine transporter imaging.
    Costa DC; Walker Z; Walker RW; Fontes FR
    Mov Disord; 2003 Oct; 18 Suppl 7():S34-8. PubMed ID: 14531044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of the dopaminergic system in differential diagnosis of dementia.
    Tatsch K
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35 Suppl 1():S51-7. PubMed ID: 18214473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
    Lim SM; Katsifis A; Villemagne VL; Best R; Jones G; Saling M; Bradshaw J; Merory J; Woodward M; Hopwood M; Rowe CC
    J Nucl Med; 2009 Oct; 50(10):1638-45. PubMed ID: 19759102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies.
    Pasquier J; Michel BF; Brenot-Rossi I; Hassan-Sebbag N; Sauvan R; Gastaut JL
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1342-8. PubMed ID: 12271417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
    O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
    Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.
    Caminiti SP; Sala A; Iaccarino L; Beretta L; Pilotto A; Gianolli L; Iannaccone S; Magnani G; Padovani A; Ferini-Strambi L; Perani D
    Alzheimers Res Ther; 2019 Feb; 11(1):20. PubMed ID: 30797240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of neuromelanin-sensitive MRI in the diagnosis of dementia with Lewy bodies.
    Inagawa Y; Inagawa S; Takenoshita N; Yamamoto R; Tsugawa A; Yoshimura M; Saito K; Shimizu S
    PLoS One; 2024; 19(9):e0309885. PubMed ID: 39250493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo dopamine pre-synaptic receptors and antioxidant activities in patients with Alzheimer's disease, dementia with Lewy bodies and in controls. A preliminary report.
    Tabet N; Walker Z; Mantle D; Costa D; Orrell M
    Dement Geriatr Cogn Disord; 2003; 16(1):46-51. PubMed ID: 12714800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].
    Vaamonde-Gamo J; Flores-Barragán JM; Ibáñez R; Gudín M; Hernández A
    Rev Neurol; 2005 Sep 1-15; 41(5):276-9. PubMed ID: 16138284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
    Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
    Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined DaT imaging and olfactory testing for differentiating parkinsonian disorders.
    Borghammer P; Knudsen K; Østergaard K; Danielsen EH; Pavese N; Arveschoug A; Bluhme H; Bode M; Morsing A
    Int J Clin Pract; 2014 Nov; 68(11):1345-51. PubMed ID: 24754902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Brain functional imaging in Alzheimer's disease].
    Ravasi L; Semah F
    Psychol Neuropsychiatr Vieil; 2009 Dec; 7 Spec No 1():21-7. PubMed ID: 20061230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography and single-photon emission computed tomography brain imaging in the evaluation of dementia.
    Van Heertum RL; Tikofsky RS
    Semin Nucl Med; 2003 Jan; 33(1):77-85. PubMed ID: 12605358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT.
    Hanyu H; Shimizu S; Hirao K; Kanetaka H; Sakurai H; Iwamoto T; Koizumi K; Abe K
    J Neurol Sci; 2006 Dec; 250(1-2):97-102. PubMed ID: 17005204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging.
    Villemagne VL; Okamura N; Pejoska S; Drago J; Mulligan RS; Chételat G; O'Keefe G; Jones G; Kung HF; Pontecorvo M; Masters CL; Skovronsky DM; Rowe CC
    Neurodegener Dis; 2012; 10(1-4):161-5. PubMed ID: 22261520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covariance 99mTc-exametazime SPECT patterns in Alzheimer's disease and dementia with Lewy bodies: utility in differential diagnosis.
    Colloby SJ; Taylor JP; Firbank MJ; McKeith IG; Williams ED; O'Brien JT
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):54-62. PubMed ID: 20029055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical validity of presynaptic dopaminergic imaging with 
    Sonni I; Ratib O; Boccardi M; Picco A; Herholz K; Nobili F; Varrone A;
    Neurobiol Aging; 2017 Apr; 52():228-242. PubMed ID: 28317651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nuclear medicine imaging in neurodegenerative dementias].
    Gratz S; Hahn U; Kaiser JW; Jarnig M; Schwarz J; Förstl H
    Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S5-7. PubMed ID: 18437639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
    Gilman S; Koeppe RA; Little R; An H; Junck L; Giordani B; Persad C; Heumann M; Wernette K
    Exp Neurol; 2005 Feb; 191 Suppl 1():S95-S103. PubMed ID: 15629765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.